Literature DB >> 24888765

The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons.

Alexander T Faje1, Anne Klibanski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24888765     DOI： 10.1007/s12020-014-0308-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  50 in total

1.  24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.

Authors:  Nea Kalleinen; Päivi Polo-Kantola; Kerttu Irjala; Tarja Porkka-Heiskanen; Tero Vahlberg; Arho Virkki; Olli Polo
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

2.  Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.

Authors:  P Touraine; J F Martini; B Zafrani; J C Durand; F Labaille; C Malet; A Nicolas; C Trivin; M C Postel-Vinay; F Kuttenn; P A Kelly
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas.

Authors:  Renata S Auriemma; Rosario Pivonello; Ylenia Perone; Ludovica F S Grasso; Lucia Ferreri; Chiara Simeoli; Davide Iacuaniello; Maurizio Gasperi; Annamaria Colao
Journal:  Eur J Endocrinol       Date:  2013-08-28       Impact factor: 6.664

4.  Prolactin pulsatile characteristics in postmenopausal women.

Authors:  L Katznelson; P N Riskind; V C Saxe; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

5.  Prolactin does not affect human platelet aggregation or secretion.

Authors:  Anne Q Reuwer; Rienk Nieuwland; Isabelle Fernandez; Vincent Goffin; Claudia M van Tiel; Marianne C L Schaap; René J Berckmans; John J P Kastelein; Marcel Th B Twickler
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

6.  Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.

Authors:  Sann Yu Mon; Abdulrahman Alkabbani; Amir Hamrahian; Julie N Thorton; Lawrence Kennedy; Robert Weil; Leann Olansky; Krupa Doshi; Vinne Makin; Betul Hatipoglu
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Authors:  Shelley S Tworoger; A Heather Eliassen; Bernard Rosner; Patrick Sluss; Susan E Hankinson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

8.  A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.

Authors:  J Webster; G Piscitelli; A Polli; C I Ferrari; I Ismail; M F Scanlon
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

9.  The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrhea.

Authors:  U M Fahy; P A Foster; H W Torode; M Hartog; M G Hull
Journal:  Gynecol Endocrinol       Date:  1992-09       Impact factor: 2.260

10.  Effects of prolactin on platelet activation and blood clotting.

Authors:  Jeanette Wahlberg; Linda Tillmar; Bertil Ekman; Tomas L Lindahl; Eva Landberg
Journal:  Scand J Clin Lab Invest       Date:  2013-04       Impact factor: 1.713
View more
  9 in total

1.  Surgical treatment of prolactinomas: cons.

Authors:  Eve Bloomgarden; Mark E Molitch
Journal:  Endocrine       Date:  2014-08-12       Impact factor: 3.633

Review 2.  Prolactinomas and menopause: any changes in management?

Authors:  Yona Greenman
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

3.  Management of prolactinomas: a survey of physicians from the Middle East and North Africa.

Authors:  Salem A Beshyah; Ibrahim H Sherif; Farida Chentli; Amir Hamrahian; Aly B Khalil; Hussein Raef; Mohamed El-Fikki; Selim Jambart
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 4.  Update on vertebral fractures in pituitary diseases: from research to clinical practice.

Authors:  Flaminia Carrone; Salvatore Ariano; Sara Piccini; Davide Milani; Marco Mirani; Luca Balzarini; Andrea Gerardo Lania; Gherardo Mazziotti
Journal:  Hormones (Athens)       Date:  2021-02-19       Impact factor: 2.885

Review 5.  Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.

Authors:  Adnin Zaman; Micol S Rothman
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

6.  Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Markus M Luedi; Hans Rudolf Widmer; Jürgen Beck; Luigi Mariani; Emanuel Christ
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 7.  Metabolic effects of prolactin.

Authors:  Rosa Pirchio; Chiara Graziadio; Annamaria Colao; Rosario Pivonello; Renata S Auriemma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

8.  [Prolactin-secreting microadenoma in menopausal women].

Authors:  Ines Barka; Emna Dendana; Nesrine Chikhrouhou; Amel Maroufi; Maha Kacem; Molka Chadli; Koussay Ach
Journal:  Pan Afr Med J       Date:  2017-07-05

9.  Management of prolactinoma: a survey of endocrinologists in China.

Authors:  Lijin Ji; Na Yi; Qi Zhang; Shuo Zhang; Xiaoxia Liu; Hongli Shi; Bin Lu
Journal:  Endocr Connect       Date:  2018-10-01       Impact factor: 3.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.